Philip C. Lee

Array ( [id] => 10313606 [patent_doc_number] => 20150198610 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-07-16 [patent_title] => 'Lectin Assay for Assessing Glycoforms as an Early Marker in Disease' [patent_app_type] => utility [patent_app_number] => 13/388971 [patent_app_country] => US [patent_app_date] => 2012-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2865 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335102 [patent_doc_number] => 20120201810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Use of Anti-DKK-1 Monoclonal Antibodies for the Treatment of Liver Cancer' [patent_app_type] => utility [patent_app_number] => 13/361439 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10997 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11799647 [patent_doc_number] => 09540438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/350676 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 63 [patent_no_of_words] => 28552 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13350676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335067 [patent_doc_number] => 20120201746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'HALF IMMUNOGLOBULIN BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/333545 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 94470 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107030 [patent_doc_number] => 20130280162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'uPAR-ANTAGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/996193 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11269 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9198159 [patent_doc_number] => 20130337474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'DETECTION OF ACUTE MYELOID LEUKAEMIA' [patent_app_type] => utility [patent_app_number] => 13/995347 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 14222 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429578 [patent_doc_number] => 20120251451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Renal Cell Carcinoma Biomarkers' [patent_app_type] => utility [patent_app_number] => 13/330421 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 53234 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335121 [patent_doc_number] => 20120201824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity' [patent_app_type] => utility [patent_app_number] => 13/128828 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21561 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251869 [patent_doc_number] => 20120156191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'ANTI-JAM-A ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/310840 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156191.pdf [firstpage_image] =>[orig_patent_app_number] => 13310840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9211652 [patent_doc_number] => 20140010829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'ANTIBODIES FOR TUMOR GANGLIOSIDES' [patent_app_type] => utility [patent_app_number] => 13/988696 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21145 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301933 [patent_doc_number] => 20120184494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'MULTIPLE MYELOMA PROGNOSIS AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/293880 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14013 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13293880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606118 [patent_doc_number] => 20130011430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'HUMAN CHORIONIC GONADOTROPIN (hCG) BASED VACCINE FOR PREVENTION AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/290839 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13290839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346859 [patent_doc_number] => 20120207771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'FOLATE RECEPTOR ALPHA AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR FOLATE RECEPTOR ALPHA-EXPRESSING CANCERS' [patent_app_type] => utility [patent_app_number] => 13/289892 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 48858 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173949 [patent_doc_number] => 20130315934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Methods and Compositions for Assessing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 13/881623 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 33317 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8906785 [patent_doc_number] => 20130174288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'ANTIBODIES FOR THE TREATMENT OF HIV' [patent_app_type] => utility [patent_app_number] => 13/823182 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23303 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043781 [patent_doc_number] => 20120071635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING TUMOR CELL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/268020 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 6889 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071635.pdf [firstpage_image] =>[orig_patent_app_number] => 13268020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003083 [patent_doc_number] => 20130224208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'GLIOMA TREATMENT METHOD, GLIOMA TESTING METHOD, METHOD FOR DELIVERING DESIRED SUBSTANCE TO GLIOMA, AND DRUGS USED IN THESE METHODS' [patent_app_type] => utility [patent_app_number] => 13/877023 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 16177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9174389 [patent_doc_number] => 20130316374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'BREAST CANCER DIAGNOSTICS' [patent_app_type] => utility [patent_app_number] => 13/825502 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12941 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335042 [patent_doc_number] => 20120201750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'SERUM BIOMARKERS FOR MELANOMA METASTASIS' [patent_app_type] => utility [patent_app_number] => 13/237377 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19838 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13237377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707522 [patent_doc_number] => 20130064811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Methods to Enhance Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 13/228603 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7208 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228603 [rel_patent_id] =>[rel_patent_doc_number] =>)